Sai Parenterals secures ₹50 crore equity investment
Sai Parenterals secured ₹50 crore equity investment from marquee investors, including Samarsh Capital, Vyom Partners, and Blue Lotus Capital. The funds will support global expansion, asset acquisitions, and manufacturing upgrades. Sai operates five facilities in India and aims to grow its presence in regulated markets with a focus on sterile injectables and CDMO services.